INTRODUCTION
Hepatolenticular degradation (Wilson's disease) is an autosomal recessive inherited disorder characterized by copper biliary excretion defect resulting in excessive copper accumulation in the liver, brain, kidney and cornea [1] . Development of severe, potentially life-threatening injury of the liver and central nervous system -if not treated with penicylamin, trientin or zinc -inevitably leads to total outcome [2] . Hepatolenticular degradation is characterized by a heterogeneous clinical feature partially depending on age at the diagnosis time [2, 3] .
As demonstrated on a large group of patients, in 42% of cases the first Wilson's disease clinical sign was liver injury, in 34%-neurological symptoms mainly resulting from injury of the extra pyramidal system, in 12%-hematological dysfunction, in 10%-mental disorders, in 1%-kidney dysfunction [3] . Thus hepatolenticular degradation should be taken into account in the differential diagnosis of several diseases. As a first case described we present here a atypical clinical feature of Wilson's disease imitating insulinoma symptoms.
CASE REPORT
A 23-year-old woman admitted to hospital due to recurrent hypoglycemia (glucose blood level 37-55 mg/dl measured with glucometer on the ambulatory basis). The patient reported symptoms of paroxysmal hyperhidrosis, pallor, hand tremor and palpitations that occurred approximately 30 months earlier. The symptoms appeared mostly in the morning, late in the afternoon, on exertion and while fasting. Though irregular and of various duration, episodes of hypoglycemia became more frequent and severe in the last three months. During that period of time sight disorders, hypersomnia, seizures, and transient motoric disorder were observed. Prodromal symptoms preceding syncope, which occurred for the first time in 2003, became more frequent. Fainting episodes were mild due to patients awareness (sugar intake in a prodromal period) although one of them resulted in non-severe head injury. Family history was negative except type 2 diabetes in his grandfather on the father's side. The patient was hospitalized twice in the internal hard and once in the neurological ward. The last hospital stay preceded the present odmission by 2 weeks. The patient presented hypoalbuminemia, coagulation abnormalities, indicator liver enzymes elevation and normal ultrasound scan of the liver and therefore had been discharged from hospital with the liver injury diagnosis after symptomatic therapy. According to clinical feature insulinoma a specific diagnostic procedure was performed. Diagnostic fasting test, performed as "gold standard" in insulinoma [4, 5] had to be interrupted after 36 hours because of a sudden presyncope with neuroglycoWhipple's triad as a clinical manifestation of hepatolenticular degeneration penia and autonomic nervous system hypersensitivity. A test result negated the insulinoma diagnosis because serum glucose, insulin and peptide C levels decreased concurrently during 6 hours' interval blood tests. Hypoglycemia (42 mg/dl) with no measurable insulin and peptide C levels after the test completion were observed (at the beginning of the test: 15.2 mIU/l and 1.2 ng/ml respectively). Therefore, normal pancreatic insulin secretion (absent in insulinoma) was proven. Furthermore, low normal glucose serum level increase in glucagon test was observed with maximum of 35 mg/dl after 30 minutes. NMR spectroscopy of the liver and pancreas was negative.
Other plausible reasons of hypoglycemia [6, 7] , presented below, were excluded: 1) insulin and sulphonylurea derivatives drug-induced hypoglycemia 2) chronic renal failure 3) nesidioblastosis 4) other pancreas dysfunction 5) hormone deficiency: a) hypothyroidism (TSH-1.67 mIU/l, fT 4 [8] . Notwithstanding ultrasound of the liver remained normal as well as NMR liver spectroscopy with mild hypertension of portal system in Doppler ultrasonography (no esophageal varices in endoscopy). The biopsy of the liver was not done due to clinical and laboratory signs of bleeding. The patient received penicylamin ands symptomatic treatment (albumins, plasma concentrate, and vitamin K). Penicylamin had to be replaced with zinc sulphate (75 mg/d in three doses) after two weeks of treatment because of thrombocytopenia. A significant improvement of patients general condition was observed with hipoproteinemia and normalization of hemorrhagic abnormalities. Currently hypoglycemia has been absent despite two episodes at the beginning of treatment. The patient now remains in good condition, with no symptoms or signs present, and he leads an active life.
DISCUSSION
The case presented here is the first from published data with clinical picture of Wilson's disease resembling insulinoma. Whipple's triad, typically occurring in insulinoma was described: 1) clinical signs triggered off by fasting or exertion; 2) hypoglycemia (<45 mg/dl) with clinical manifestation, and 3) yielding of clinical signs after food intake. As observed in insulinoma, the patient presented symptoms of neuroglycopenia as well as increased catecholamine level. The only difference was no weight gain usually observed in insulinoma and young age of patient (insulinoma usually is diagnosed between 40 and 60 years of age).
While it is true that Wilson's disease leads to hypoglycemia, it is usually observed in the late stage of disease when liver failure develops [2] and therefore hypoglycemia was associated with typical manifestation of hepatolenticular degeneration [2] . Normal ultrasound scan and NMR spectroscopy, and mild hypertension of portal system, confirmed that hypoglycemia can develop on an early stage of the disease and can appear as the first clinical manifestation. Other causes of hypoglycemia were excluded [6, 7] . It has been, therefore, confirmed that the patient does not suffer from other hypoglycemia-associated disorder. Overlapping concurrent diseases were also excluded.
Efficacy of zinc sulphate treatment suggested two further conclusions. Hypoglycemia recovery together with clinical improvement (diathesis, hypoalbuminemia and liver dysfunction recovery) confirms a straightforward dependence of hypoglycemia with hepatolenticular degeneration. Secondly, hypoglycemia in Wilson's disease is reversible, if early and effective treatment has been initiated.
The case report presented proves that hepato-lenticular degeneration must be taken into consideration if hypoglycemia of unknown origin occurs. It should be also a component of differential diagnosis when clinical symptoms suggest insulinoma while biochemical markers (especially the fasting test) are negative. Normal or slightly abnormal liver scan does not exclude the diagnosis of Wilson's disease and therefore, should be verified by biochemical blood tests.
